Introduction
The Sexual Offences Act (Amendment), 1976 , in the UK defines rape as sexual intercourse with a woman without her consent, either by using force or fraudulent means.' Vaginal penetration to any degree is sufficient. The risk of acquisition of sexually transmitted diseases (STDs) after sexual assault is unknown. A recent review' highlighted the lack of data on the association between rape and STD, particularly conditions other than the traditional venereal diseases gonorrhoea and syphilis. Much of the available information has come from the microbiological assessment of women referred by police agencies in North America`5 where the legal definitions of rape and child sexual abuse differ from those in the UK and where prophylactic treatment is more readily available. These studies have not always differentiated children from adults, girls aged less than 16 years representing up to 42% of victims in one study. 6 More recently, infection with Chlamydia trachomatis has also been reported following rape. 7 The viral STDs, namely human papilloma virus (HPV), herpes simplex virus (HSV), cytomegalovirus (CMV), hepatitis B virus (HBV), human immunodeficiency virus (HIV) and molluscum contagiosum may be acquired through rape. However, only two studies and one case report have considered the risk of acquisition of these infections. In a study7 of 46 women one had a four week history of genital warts, having attended 12 months after rape. No voluntary sexual activity had occurred between the assault and her initial visit. HSV infection was not reported in these patients and none were tested for antibodies to HIV. In a more recent study,8 204 women were reviewed within 72 hours of rape by an unknown assailant or assailants. No cases of genital warts were reported. However, 13 weeks) and 76 (61 %) attended for a second review at a mean of 11 weeks (range 1-100).
Most of the women, 69 (56%), were self-referred.
Other sources of referral are shown in table 1 . The rape had been reported to the police by 58 women The most common viral infection was with HPV in the form of genital warts, being present in 11 (9%) patients. In five women the warts were not detected at their initial visit but only on follow up. This suggests that the infection either did not pre-date the rape or that at the initial visit the patient had subclinical disease. Eight of this group had one or more coexistent STD. It is possible that cases of wart virus infection were missed because of the long incubation period and that additional cases may have been detected on extended review. The use of the colposcope may have increased the yield of HPV detection but has the disadvantage of being perceived as an additional trauma by the rape victim. Although DNA typing was not undertaken in this study it may be desirable in providing medico-legal evidence.
Two women had evidence of symptomatic HSV infection. In both cases these were unlikely to have been associated with the rape. However, inapparent HSV infection would not have been detected in this study since viral cultures were only performed on clinical grounds. HSV is often complicated by psychological morbidity.'4 This problem could be exaggerated if the infection were acquired following rape.
No acute cases of HBV infection were detected. One low risk carrier of HBV was identified 18 days after the rape. Probably all of the women with HBV markers acquired their infection prior to their assault. This is the first study to present data on HBV in victims of rape. However, if the assailant is suspected of being an infective risk, post-exposure HBV prophylaxis should be considered.`5
The increasing trend in the number of HIV tests performed from 1986 to 1988 shown in table 5 may have reflected publicity surrounding HIV at that time. Eight women attended solely because they perceived themselves to be at risk of HIV infection following rape, one decided not to be tested after counselling. Of the 24 (19%) women expressing anxiety about AIDS, seven declined HIV testing after counselling.
Only one woman had antibodies to HIV and she did not present with HIV anxiety. It was not possible to directly attribute this to the rape since antibodies were present at the initial visit two months after the rape had occurred. The HIV status of her assailant was unknown. Supporting data were presented in Jenny's series from Seattle8 in which no seroconversions were recorded in 123 patients, of whom 52 (42%) returned for a second follow up visit at a mean of eight weeks. A recent case report of HIV seroconversion after rape9 has highlighted this potential risk for rape victims. This has prompted discussion about post-rape prophylaxis using zidovudine.9 As in the case of needle stick injury,'6 no data are available on the efficacy of this treatment. The topical use of substances with anti-HIV activity,'7 such as nonoxynol-9, following rape has been suggested but these products have not been evaluated, do not consider the possibility of multiple sites being involved and may even be harmful.'8 Discussion about HIV with a woman in such a vulnerable state following rape may not be appropriate in all cases.'9 Our practice is to save a serum sample at the initial visit to be tested when an informed decision can be made and repeated, as necessary. However, the risk of HIV transmission is small, at least in the low prevalence areas so far studied, but this may well change with time. The risk of HIV transmission may also be affected by the use of condoms by assailants, the occurrence of anal penetration, anogenital trauma and rapes by multiple assailants.
Three of six abnormal smears showed changes suggestive of significant GIN abnormalities. In view of the natural history of CIN and the relatively short time period to detection in this study it is unlikely that these abnormalities were related to the rape. However, they represent important incidental findings in need of assessment which may otherwise have remained undetected.20
The presence of an STD cannot necessarily be attributed to an assault. It is possible that the infection was present before the rape. This could be excluded in one patient with T. vaginalis infection who had been a virgin. Intercurrent antibiotics used by 10 women may have masked infection in the six women in whom no STD was detected. The antibiotics used were all potentially active against some STD.
When raped 36 (29%) women had adequate protection against pregnancy (either using the combined oral contraceptive, an intra-uterine contraceptive device or had been sterilised). Of those with inadequate contraception three became pregnant and two had terminations. Post-coital hormonal contraception had been given to 13 women; it had not been prescribed for the three women who became pregnant because they all presented more than five weeks from the assault. In patients with chlamydial infection pelvic inflammatory disease may result from termination of pregnancy`3 if these infections are not sought and treated.
The range of STD detected mitigates against the use ofprophylactic antibiotic regimes following rape. Thorough investigation and treatment of identified infection is a more satisfactory alternative. 22 However, epidemiological treatment may be appropriate if a patient cannot return for follow up and compound regimes have been suggested.2 22 Screening for STDs is only part of the overall management of rape victims. Psychological and emotional support should be made available. The patients in our study were offered immediate access to health advisers within the clinic for initial counselling. Further tiers of psychological support were provided by other statutory and voluntary agencies as appropriate.
In conclusion, we have shown that rape victims are a population at risk of having STDs. However, in only a minority of cases is it possible to attribute the STD to an assailant. Screening for STDs should now be offered in the management of rape victims. It may also be necessary to make provision for storing specimens for further analysis where medico-legal cases are likely.
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